title: Generic and low dose antiretroviral therapy in adults and children: implication for scaling up treatment in resource limited settings.
abstract: Although access to antiretroviral therapy (ART) for the treatment of HIV has increased during the last decade, many patients are still in need of treatment. With limited funds to provide ART to millions of patients worldwide, there is a need for alternative ways to scale up ART in resource limited settings. This review provides an overview of pharmacokinetic, safety and efficacy studies of generic and reduced dose ART. The production of generic ART has greatly influenced the decline in drug prices and the increased in ART access. Generic ART has good pharmacokinetic profile, safety and efficacy. Toxicity is however the main cause for ART discontinuation. Several dose reduction studies have shown adequate pharmacokinetic parameters and short term efficacy with reduced dose ART. Ethnicity may affect drug metabolism; several pharmacokinetic studies have confirmed higher plasma ART concentration in Asians. Randomized efficacy trial of reduced versus standard ART is warranted.
authors.affiliation: The HIV Netherlands Australia Thailand Research Collaboration (HIVNAT), Bangkok, Thailand. jintanat.a@hivnat.org.
authors.forename: Reshmie
authors.initials: R
authors.lastname: Ramautarsing
authors.forename: Jintanat
authors.initials: J
authors.lastname: Ananworanich